Technical Study: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura Pharmaceuticals Inc. Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON, September 17, 2013 LONDON, September 17, 2013 /PRNewswire/ -- The U.S. equity market finished on a mixed note on Monday, September 16, 2013. The S&P 500 and the Dow Jones posted gains, while the NASDAQ Composite ended slightly lower. Shares in the healthcare sector ended mostly higher, even as the broader market finished on a mixed note. The major movers in the sector included VIVUS Inc. (NASDAQ: VVUS), Sanofi (NYSE: SNY), DENTSPLY International Inc. (NASDAQ: XRAY), and Acura Pharmaceuticals Inc. (NASDAQ: ACUR). AAAResearchReports.com free coverage on VVUS, SNY, XRAY, and ACUR is available upon registration at: http://www.aaaresearchreports.com/register/ Shares in VIVUS Inc. rose sharply on Monday, even as the broader market finished on a mixed note. The company's shares closed the day at $10.33, up 2.08% from the previous day's price of $10.12. A total of 1.64 million shares were traded, which is below the daily average volume of 2.55 million. Despite Monday's sharp gains, the company's shares have lost 0.77% in the previous three trading sessions, underperforming the S&P 500 which has gained 0.50% during the same period. Further, VIVUS Inc.'s stock is trading below its 50-day and 200-day moving averages of $13.05 and $12.17, respectively. Download free technical research on VVUS by signing up at: http://www.AAAResearchReports.com/VVUS091713.pdf Sanofi's stock fluctuated between gains and losses before finishing the day nearly flat on Monday. The company's shares closed the day at $47.95, down 0.02%, after oscillating between $47.95 and $48.48. A total of 2.39 million shares were traded, which is below the daily average volume of 1.81 million. Sanofi's shares have lost 2.56% in the last three trading sessions, underperforming the S&P 500 which has gained 0.50% during the same period. Furthermore, the company's stock is currently trading below its 50-day and 200-day moving averages of $51.02 and $50.47, respectively. Register now and get access to free analysis on SNY at: http://www.AAAResearchReports.com/SNY09713.pdf Shares in DENTSPLY International Inc. moved higher on Monday, even as the U.S. equity market ended on a mixed note. The company's shares fluctuated between $44.47 and $45.06 before closing the day 0.97% higher at $44.54. A total of 0.84 million shares were traded, which is more than the daily average volume of 0.75 million. The company's shares have surged 8.61% in the previous three months and 6.10% in the last one month, outperforming the S&P 500 which has gained 4.36% and 2.52% during the respective periods. Further, DENTSPLY International Inc.'s stock has moved closer to its 52-week high of $45.37 and is currently trading above its 50-day and 200-day moving averages of $42.47 and $41.67, respectively. Sign up and read our complimentary report on XRAY at: http://www.AAAResearchReports.com/XRAY091713.pdf Acura Pharmaceuticals Inc.'s shares fluctuated between gains and losses before finishing flat on Monday. The company's shares closed the day at the previous day's closing price of $1.49 after oscillating between $1.46 and $1.53 during the trading session. A total of 0.09 million shares were traded, which is below the daily average volume of 0.39 million. Acura Pharmaceuticals Inc.'s shares have lost 0.67% in the last three trading sessions, underperforming the S&P 500 which has gained 0.50% during the same period. Additionally, the company's stock is currently trading below its 50-day and 200-day moving averages of $1.78 and $2.12, respectively. The free report on ACUR can be downloaded by signing up now at: http://www.AAAResearchReports.com/ACUR091713.pdf ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. AAAresearchreports.com SOURCE AAA Research Reports Contact: +1(646)396-9126, Peter F. Jones, email@example.com
Technical Study: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura Pharmaceuticals Inc.
Press spacebar to pause and continue. Press esc to stop.